- Home
- LXFR vs ABEO Comparison
LXFR vs ABEO Comparison
Compare LXFR & ABEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LXFR
- ABEO
- Stock Information
- Founded
- LXFR 1898
- ABEO 1974
- Country
- LXFR United States
- ABEO United States
- Employees
- LXFR N/A
- ABEO N/A
- Industry
- LXFR Major Chemicals
- ABEO Biotechnology: Pharmaceutical Preparations
- Sector
- LXFR Industrials
- ABEO Health Care
- Exchange
- LXFR Nasdaq
- ABEO Nasdaq
- Market Cap
- LXFR 335.4M
- ABEO 332.0M
- IPO Year
- LXFR 2012
- ABEO 1980
- Fundamental
- Price
- LXFR $13.42
- ABEO $6.83
- Analyst Decision
- LXFR
- ABEO Strong Buy
- Analyst Count
- LXFR 0
- ABEO 6
- Target Price
- LXFR N/A
- ABEO $18.17
- AVG Volume (30 Days)
- LXFR 135.6K
- ABEO 702.3K
- Earning Date
- LXFR 10-28-2025
- ABEO 08-14-2025
- Dividend Yield
- LXFR 3.87%
- ABEO N/A
- EPS Growth
- LXFR N/A
- ABEO N/A
- EPS
- LXFR 0.90
- ABEO 0.99
- Revenue
- LXFR $403,800,000.00
- ABEO $400,000.00
- Revenue This Year
- LXFR $3.12
- ABEO N/A
- Revenue Next Year
- LXFR $3.31
- ABEO $339.63
- P/E Ratio
- LXFR $13.74
- ABEO $6.91
- Revenue Growth
- LXFR 5.60
- ABEO N/A
- 52 Week Low
- LXFR $9.41
- ABEO $3.93
- 52 Week High
- LXFR $15.64
- ABEO $7.54
- Technical
- Relative Strength Index (RSI)
- LXFR 64.00
- ABEO 52.71
- Support Level
- LXFR $12.32
- ABEO $6.70
- Resistance Level
- LXFR $13.86
- ABEO $7.15
- Average True Range (ATR)
- LXFR 0.45
- ABEO 0.31
- MACD
- LXFR 0.11
- ABEO -0.02
- Stochastic Oscillator
- LXFR 78.85
- ABEO 46.62
About LXFR Luxfer Holdings PLC
Luxfer Holdings PLC is a manufacturer industrial company innovating niche applications in materials engineering. It focuses on value creation by using its broad array of technical know-how and proprietary technologies to help create a safe, clean, and energy-efficient world. Luxfer's high-performance materials, components, and high-pressure gas containment devices are used in defense, first response and healthcare, transportation, and general industrial applications. It focuses on product lines related to magnesium alloys, zirconium chemicals, and carbon composites. Its segments are Elektron, Gas Cylinders, and Graphic Arts. It generates the majority of its revenue from Elektron and as well as Gas Cylinders.
About ABEO Abeona Therapeutics Inc.
Abeona Therapeutics Inc is a clinical-stage biopharmaceutical company. The firm is focused on developing gene therapies and plasma-based products for life-threatening rare genetic diseases. Its clinical programs consist of pz-cel, an autologous, engineered cell therapy currently in development for recessive dystrophic epidermolysis bullosa (RDEB). The Company's development portfolio also features adeno-associated virus (AAV)-based gene therapies designed to treat unmet, medically needed ophthalmic diseases using the novel.